Author:
Lehmann-Che J,Amira-Bouhidel F,Turpin E,Antoine M,Soliman H,Legres L,Bocquet C,Bernoud R,Flandre E,Varna M,de Roquancourt A,Plassa L-F,Giacchetti S,Espié M,de Bazelaire C,Cahen-Doidy L,Bourstyn E,Janin A,de Thé H,Bertheau P
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Apple SK, Lowe AC, Rao PN, Shintaku IP, Moatamed NA (2009) Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Mod Pathol 22: 1151–1159
2. Barberis M, Pellegrini C, Cannone M, Arizzi C, Coggi G, Bosari S (2008) Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysis. Am J Clin Pathol 129: 563–570
3. Bergqvist J, Ohd JF, Smeds J, Klaar S, Isola J, Nordgren H, Elmberger GP, Hellborg H, Bjohle J, Borg AL, Skoog L, Bergh J (2007) Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome. Ann Oncol 18: 845–850
4. Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckersberger D, Gnant M, Jakesz R (2001) Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res 7: 1669–1675
5. Bossard C, Bieche I, Le Doussal V, Lidereau R, Sabourin JC (2005) Real-time RT-PCR: a complementary method to detect HER-2 status in breast carcinoma. Anticancer Res 25: 4679–4683
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献